A phase II trial for glioblastoma (GBM) patients with MGMT unmethylation reported that the mTOR inhibitor temsirolimus could prolong overall survival in patients with mTORSer2448 phosphorylation.9 This evidence concerns the gene MTOR and glioblastoma.